GO:0033320 UDP-D-xylose biosynthetic process: Nucleotide Sugar Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033320 describes the chemical reactions and pathways that produce UDP-D-xylose, a nucleotide sugar used in glycosylation and cell wall biosynthesis [2, 5].
• In plants, UDP-D-xylose is generated primarily by UDP-xylose synthase (UXS) and bifunctional UDP-glucose 4-epimerases that interconvert UDP-D-xylose and UDP-L-arabinose [5, 6].
• UDP-D-xylose is a substrate for xylosyltransferases that modify proteoglycans and glycoproteins, including the Xyl alpha 1-3Glc beta-Ser structure in human hepatoma cells [1, 8].
• Depletion of UDP-D-apiose/UDP-D-xylose synthases causes rhamnogalacturonan-II deficiency, cell wall thickening, and cell death in higher plants.
• Engineered Saccharomyces cerevisiae can serve as a biosynthetic platform for producing nucleotide sugars such as UDP-D-xylose.
• The pathway is conserved from algae to humans, making it a target for cell wall, glycobiology, and metabolic engineering research [2, 7].
Description
UDP-D-xylose biosynthetic process (GO:0033320) is the set of biochemical reactions that generate uridinediphosphoxylose, a nucleotide sugar composed of xylose linked to uridine diphosphate [2, 5]. This process is essential for providing activated xylose for glycosyltransferase reactions that build complex carbohydrates, proteoglycans, and plant cell wall polysaccharides [1, 3, 8]. The pathway has been studied in organisms ranging from algae to plants and humans, reflecting its fundamental role in glycobiology [2, 7]. In plants, UDP-D-xylose is synthesized by UDP-xylose synthase and related enzymes, and it is also interconverted with UDP-L-arabinose by bifunctional UDP-glucose 4-epimerases [5, 6]. In humans, UDP-D-xylose serves as a donor substrate for xylosyltransferases that initiate glycosaminoglycan attachment to proteoglycans [1, 8]. Understanding GO:0033320 is therefore critical for researchers in plant biology, glycobiology, and metabolic engineering who seek to manipulate cell wall composition or glycosylation patterns [3, 4].
UDP-D-xylose biosynthetic process At A Glance
| GO ID | GO:0033320 |
|---|---|
| GO term | UDP-D-xylose biosynthetic process |
| Ontology | biological_process |
| Synonym | UDP-D-xylose anabolism, UDP-D-xylose biosynthesis, UDP-D-xylose formation, UDP-D-xylose synthesis |
| Major function | Production of UDP-D-xylose for glycosylation and cell wall biosynthesis |
| Key enzymes | UDP-xylose synthase (UXS), UDP-D-apiose/UDP-D-xylose synthase (AXS), UDP-glucose 4-epimerase |
| Substrate | UDP-D-glucuronic acid or UDP-D-glucose (via epimerization) |
| Product | UDP-D-xylose |
| Organisms | Algae, plants, yeast, humans |
What Is GO:0033320?
GO:0033320, UDP-D-xylose biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of UDP-D-xylose, a substance composed of xylose in glycosidic linkage with uridine diphosphate. In simpler terms, it is the biological process by which cells produce the activated sugar UDP-D-xylose, which is then used by enzymes to add xylose to other molecules [2, 5].
Why Is UDP-D-xylose biosynthetic process Important in Cell Biology?
UDP-D-xylose biosynthetic process is important because UDP-D-xylose is a key nucleotide sugar donor for xylosyltransferases that modify proteoglycans, glycoproteins, and plant cell wall polysaccharides [1, 3, 8]. Disruption of this pathway leads to severe cell wall defects in plants, including rhamnogalacturonan-II deficiency and cell death, highlighting its essential role in growth and development. In humans, UDP-D-xylose is required for the biosynthesis of the Xyl alpha 1-3Glc beta-Ser structure in glycoproteins, which is relevant to liver cancer cell biology. The pathway is also a target for metabolic engineering, as engineered yeast can produce nucleotide sugars for biotechnological applications.
• Provides UDP-D-xylose for xylosyltransferase reactions in proteoglycan and glycoprotein biosynthesis [1, 8].
• Essential for plant cell wall integrity; depletion causes rhamnogalacturonan-II deficiency and cell death.
• Involved in the interconversion between UDP-D-xylose and UDP-L-arabinose in plants.
• Conserved from algae to humans, indicating fundamental biological importance [2, 7].
• Enables metabolic engineering of nucleotide sugar production in yeast.
• Relevant to cancer biology through glycoprotein modification in hepatoma cells.
• Target for understanding glycosylation disorders and cell wall-related diseases [3, 8].
• Provides tools for studying enzyme families such as UXS and AXS [6, 7].
What Happens During UDP-D-xylose biosynthetic process?
Formation of UDP-D-xylose from UDP-D-glucuronic acid
In simple terms: A sugar building block is converted into another sugar building block.
In plants, UDP-D-xylose is primarily synthesized by UDP-xylose synthase (UXS), which decarboxylates UDP-D-glucuronic acid to form UDP-D-xylose [5, 6]. This reaction is a key step in the pathway and has been characterized in several plant species, including Ornithogalum caudatum. The enzyme belongs to the short-chain dehydrogenase/reductase family and requires NAD+ as a cofactor.
Interconversion with UDP-L-arabinose
In simple terms: Two similar sugars can be converted back and forth.
Bifunctional cytosolic UDP-glucose 4-epimerases catalyze the interconversion between UDP-D-xylose and UDP-L-arabinose in plants. This reversible reaction allows the cell to balance the pools of these two nucleotide sugars, which are both used in cell wall polysaccharide biosynthesis.
Alternative route via UDP-D-apiose/UDP-D-xylose synthase
In simple terms: Another enzyme can also make UDP-D-xylose while producing a different sugar.
UDP-D-apiose/UDP-D-xylose synthase (AXS) catalyzes the conversion of UDP-D-glucuronic acid to both UDP-D-apiose and UDP-D-xylose [3, 7]. This enzyme was functionally cloned and characterized from Arabidopsis thaliana, and its depletion results in rhamnogalacturonan-II deficiency, cell wall thickening, and cell death in higher plants [3, 7].
UDP-D-xylose as a substrate for xylosyltransferases
In simple terms: The product is used to attach xylose to other molecules.
UDP-D-xylose serves as the donor substrate for UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferase, which initiates glycosaminoglycan chain attachment to proteoglycans. In human hepatoma cells, UDP-D-xylose: beta-D-glucoside alpha-1,3-D-xylosyltransferase uses UDP-D-xylose to form the Xyl alpha 1-3Glc beta-Ser structure of glycoproteins.
Biosynthetic platform in engineered yeast
In simple terms: Yeast can be engineered to produce UDP-D-xylose for industrial use.
Engineered Saccharomyces cerevisiae has been developed as a biosynthetic platform for nucleotide sugars, including UDP-D-xylose. This approach enables the production of UDP-D-xylose and other nucleotide sugars for biotechnological applications, such as in vitro glycosylation reactions.
Key Genes Involved in GO:0033320 UDP-D-xylose biosynthetic process
The following genes and enzymes are experimentally implicated in UDP-D-xylose biosynthetic process (GO:0033320) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UXS1 (UDP-xylose synthase) | Converts UDP-D-glucuronic acid to UDP-D-xylose | Key enzyme in plant and algal UDP-D-xylose biosynthesis [2, 6] |
| AXS1 (UDP-D-apiose/UDP-D-xylose synthase) | Produces UDP-D-xylose and UDP-D-apiose from UDP-D-glucuronic acid | Essential for cell wall integrity; depletion causes cell death [3, 7] |
| UGE1 (UDP-glucose 4-epimerase) | Interconverts UDP-D-xylose and UDP-L-arabinose | Regulates nucleotide sugar pools in plants |
| UXS2 | UDP-xylose synthase family member | Functional characterization in Ornithogalum caudatum |
| UXS3 | UDP-xylose synthase family member | Transcriptome-guided isolation and characterization |
| AXS2 | UDP-D-apiose/UDP-D-xylose synthase family member | Functional characterization in plants |
| XYLT1 | Xylosyltransferase that uses UDP-D-xylose | Initiates proteoglycan glycosaminoglycan synthesis |
| XYLT2 | Xylosyltransferase that uses UDP-D-xylose | Proteoglycan biosynthesis |
| B4GALT7 | Beta-1,4-galactosyltransferase | Downstream of xylosylation in proteoglycan synthesis |
| GUSB | Beta-glucuronidase | Involved in glycosaminoglycan degradation |
| UGDH | UDP-glucose 6-dehydrogenase | Produces UDP-D-glucuronic acid, a precursor for UDP-D-xylose |
| UGP1 | UDP-glucose pyrophosphorylase | Provides UDP-glucose for nucleotide sugar interconversion |
| UXS4 | UDP-xylose synthase family member | Potential role in plant cell wall biosynthesis |
| AXS3 | UDP-D-apiose/UDP-D-xylose synthase family member | Functional characterization in plants |
| XYLT1 (human) | Xylosyltransferase | Relevant to human glycoprotein biosynthesis |
| XYLT2 (human) | Xylosyltransferase | Relevant to human glycoprotein biosynthesis |
| SLC35B4 | UDP-xylose transporter | Transports UDP-D-xylose into Golgi for glycosylation |
| SLC35D1 | UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter | Indirectly affects UDP-D-xylose availability |
How Is UDP-D-xylose biosynthetic process Regulated?
The UDP-D-xylose biosynthetic process is regulated at multiple levels. In plants, the expression of UDP-xylose synthase and UDP-D-apiose/UDP-D-xylose synthase genes is transcriptionally controlled during development and in response to cell wall stress [3, 6]. The bifunctional UDP-glucose 4-epimerases that interconvert UDP-D-xylose and UDP-L-arabinose are also regulated to maintain nucleotide sugar homeostasis. In engineered yeast, metabolic engineering strategies have been used to redirect flux toward UDP-D-xylose production by overexpressing pathway enzymes and deleting competing reactions. Additionally, the availability of UDP-D-glucuronic acid, the substrate for UXS and AXS, is controlled by UDP-glucose 6-dehydrogenase (UGDH).
UDP-D-xylose biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AXS1 | Cell wall deficiency and cell death in plants | Arabidopsis knockout |
| UXS1 | Altered cell wall composition | Plant knockout or overexpression |
| XYLT1 | Proteoglycan biosynthesis defects | Human cell line knockout |
| XYLT2 | Connective tissue disorders | Knockout mouse or human cells |
| XYLT1 (HepG2) | Cancer glycoprotein modification | HepG2 cell line knockout |
Cell wall-related disorders in plants
Depletion of UDP-D-apiose/UDP-D-xylose synthases in Arabidopsis leads to rhamnogalacturonan-II deficiency, cell wall thickening, and cell death, demonstrating that GO:0033320 is essential for plant cell wall integrity and development. These findings have implications for understanding plant growth defects and for engineering crops with altered cell wall properties [3, 7].
Cancer glycobiology
In human hepatoma cell line HepG2, UDP-D-xylose: beta-D-glucoside alpha-1,3-D-xylosyltransferase is involved in the biosynthesis of the Xyl alpha 1-3Glc beta-Ser structure of glycoproteins. Altered glycosylation is a hallmark of cancer, and enzymes using UDP-D-xylose may contribute to tumor-associated glycoprotein changes.
Proteoglycan-related diseases
UDP-D-xylose is the donor substrate for xylosyltransferases that initiate glycosaminoglycan attachment to proteoglycan core proteins. Defects in this process can affect connective tissue and extracellular matrix biology, although direct human diseases linked to GO:0033320 are not fully characterized.
From UDP-D-xylose biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of UXS1 affect UDP-D-xylose levels? | CRISPR knockout in plant or human cells |
| Does AXS1 depletion cause cell wall defects? | Arabidopsis knockout |
| Can point mutations in UXS alter substrate specificity? | CRISPR point mutation knock-in |
| Does overexpression of UGDH increase UDP-D-xylose production? | Overexpression cell line |
| Can tagged UXS be used to study subcellular localization? | Tagged knock-in |
| Does XYLT1 knockout alter proteoglycan glycosylation? | Human cell line knockout |
How to Study the UDP-D-xylose biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transcriptome-guided gene isolation | Identification of UXS and AXS genes | Plant gene discovery |
| Radiolabeled substrate assay | UDP-D-xylose formation | Algal enzyme characterization |
| Xylosyltransferase assay with silk | Enzyme activity using UDP-D-xylose | Proteoglycan research |
| HPLC/mass spectrometry | Nucleotide sugar levels | Metabolic engineering |
| CRISPR knockout | Gene function in pathway | Plant and human cell models [3, 6] |
| Overexpression | Increased pathway flux | Biotechnological production |
| Subcellular localization | Enzyme compartmentalization | Tagged knock-in |
| Cell wall composition analysis | Rhamnogalacturonan-II levels | Plant cell wall studies |
Transcriptome-guided gene isolation
Transcriptome analysis has been used to isolate and functionally characterize UDP-xylose synthase and UDP-D-apiose/UDP-D-xylose synthase families from Ornithogalum caudatum, enabling the identification of genes involved in GO:0033320.
Enzymatic assays with radiolabeled substrates
The formation of UDP-D-xylose in algae was demonstrated using enzymatic assays with radiolabeled precursors, providing direct biochemical evidence for the pathway.
Glycosyltransferase activity assays
UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferase activity can be measured using silk as a substrate, as described in the original assay. Similarly, UDP-D-xylose: beta-D-glucoside alpha-1,3-D-xylosyltransferase activity has been measured in HepG2 cells.
Metabolic engineering and nucleotide sugar analysis
Engineered Saccharomyces cerevisiae strains can be used to produce UDP-D-xylose, and nucleotide sugars can be analyzed by HPLC or mass spectrometry to quantify pathway flux.
How CRISPR Can Be Used to Study GO:0033320 UDP-D-xylose biosynthetic process
Knockout
CRISPR knockout of UXS1 or AXS1 can be used to eliminate UDP-D-xylose biosynthetic process, leading to reduced UDP-D-xylose levels and downstream effects on cell wall integrity or glycosylation [3, 6]. In Arabidopsis, AXS1 knockout results in rhamnogalacturonan-II deficiency and cell death.
Point Mutation
CRISPR point mutation knock-in can be used to introduce catalytic dead mutations or substrate-specificity changes in UXS or AXS enzymes, allowing precise dissection of their roles in GO:0033320.
Knock-in
Tagged knock-in of UXS or AXS with fluorescent or affinity tags enables visualization and purification of these enzymes to study their localization and interactions within the UDP-D-xylose biosynthetic pathway.
Overexpression
CRISPR activation or cDNA overexpression of UXS, AXS, or UGDH can increase UDP-D-xylose production, which is useful for metabolic engineering and for studying downstream glycosylation effects [4, 5].
How EDITGENE Supports UDP-D-xylose biosynthetic process Research
Researchers studying UDP-D-xylose biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in UDP-D-xylose production, cell wall biosynthesis, or glycoprotein modification. EDITGENE provides CRISPR-based cell model services to enable precise functional interrogation of genes in this pathway.
Contact EDITGENE today to design your custom CRISPR model for UDP-D-xylose biosynthetic process research.
Frequently Asked Questions About UDP-D-xylose biosynthetic process
What is UDP-D-xylose biosynthetic process?
UDP-D-xylose biosynthetic process (GO:0033320) is the set of biochemical reactions that produce UDP-D-xylose, a nucleotide sugar used in glycosylation and cell wall biosynthesis [2, 5].
What genes are involved in UDP-D-xylose biosynthetic process?
Key genes include UXS1, AXS1, UGE1, UGDH, and XYLT1, which encode enzymes that synthesize or utilize UDP-D-xylose [3, 5, 6, 8].
What is the function of UDP-D-xylose?
UDP-D-xylose serves as a donor substrate for xylosyltransferases that modify proteoglycans, glycoproteins, and plant cell wall polysaccharides [1, 3, 8].
How is UDP-D-xylose synthesized in plants?
In plants, UDP-D-xylose is synthesized by UDP-xylose synthase (UXS) and UDP-D-apiose/UDP-D-xylose synthase (AXS) from UDP-D-glucuronic acid, and interconverted with UDP-L-arabinose by UDP-glucose 4-epimerases [3, 5, 6].
What happens when UDP-D-xylose biosynthesis is disrupted?
Disruption leads to rhamnogalacturonan-II deficiency, cell wall thickening, and cell death in plants, and may affect glycoprotein biosynthesis in human cells [3, 8].
Is UDP-D-xylose biosynthetic process conserved in humans?
Yes, humans use UDP-D-xylose for xylosyltransferase reactions in proteoglycan and glycoprotein biosynthesis, as shown in HepG2 cells [1, 8].
What enzymes use UDP-D-xylose?
UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferase and UDP-D-xylose: beta-D-glucoside alpha-1,3-D-xylosyltransferase use UDP-D-xylose as a substrate [1, 8].
Can yeast be engineered to produce UDP-D-xylose?
Yes, engineered Saccharomyces cerevisiae can serve as a biosynthetic platform for nucleotide sugars including UDP-D-xylose.
What methods are used to study UDP-D-xylose biosynthetic process?
Methods include transcriptome-guided gene isolation, radiolabeled substrate assays, xylosyltransferase activity assays, and metabolic engineering with nucleotide sugar analysis [1, 2, 4, 6].
How can CRISPR help study UDP-D-xylose biosynthetic process?
CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of genes such as UXS1 and AXS1 in this pathway [3, 6].
Conclusion
UDP-D-xylose biosynthetic process (GO:0033320) is a fundamental metabolic pathway that produces a key nucleotide sugar for glycosylation and cell wall biosynthesis across organisms [2, 5]. Its disruption causes severe cell wall defects in plants and affects glycoprotein modification in human cells, underscoring its biological importance [3, 8]. Researchers can leverage CRISPR-based models and biochemical assays to dissect the pathway and develop biotechnological applications [4, 6].
References
- 1. Campbell P et al.. 1984. Silk--a new substrate for UDP-d-xylose:proteoglycan core protein beta-D-xylosyltransferase.. Anal Biochem 137(2):505-16 PMID: 6731831
- 2. Ankel H et al.. 1967. Formation of UDP-D-xylose in algae.. Biochim Biophys Acta 136(1):172-5 PMID: 6040409
- 3. Ahn JW et al.. 2006. Depletion of UDP-D-apiose/UDP-D-xylose synthases results in rhamnogalacturonan-II deficiency, cell wall thickening, and cell death in higher plants.. J Biol Chem 281(19):13708-13716 PMID: 16549428
- 4. Crowe SA et al.. 2024. Engineered Saccharomyces cerevisiae as a Biosynthetic Platform of Nucleotide Sugars.. ACS Synth Biol 13(4):1215-1224 PMID: 38467016
- 5. Kotake T et al.. 2009. Bifunctional cytosolic UDP-glucose 4-epimerases catalyse the interconversion between UDP-D-xylose and UDP-L-arabinose in plants.. Biochem J 424(2):169-77 PMID: 19754426
- 6. Yin S et al.. 2016. Transcriptome-guided gene isolation and functional characterization of UDP-xylose synthase and UDP-D-apiose/UDP-D-xylose synthase families from Ornithogalum caudatum Ait.. Plant Cell Rep 35(11):2403-2421 PMID: 27591771
- 7. Mølhøj M et al.. 2003. The biosynthesis of the branched-chain sugar d-apiose in plants: functional cloning and characterization of a UDP-d-apiose/UDP-d-xylose synthase from Arabidopsis.. Plant J 35(6):693-703 PMID: 12969423
- 8. Omichi K et al.. 1997. Presence of UDP-D-xylose: beta-D-glucoside alpha-1,3-D-xylosyltransferase involved in the biosynthesis of the Xyl alpha 1-3Glc beta-Ser structure of glycoproteins in the human hepatoma cell line HepG2.. Eur J Biochem 245(1):143-6 PMID: 9128735
